Security Snapshot

MEDICINOVA INC - Common Stock (MNOV) Institutional Ownership

CUSIP: 58468P206

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

23

Shares (Excl. Options)

6.69MFull value: 6,693,601 · shares · 30 Sep 2026

Price

$1.68

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+3,482,335
Value change
+$5,837,575
Number of holders
23
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
49,287,931
SEC-reported price per share
$1.45
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • MNOV - MEDICINOVA INC - Common Stock is tracked under CUSIP 58468P206.
  • 23 institutions reported positions in Q3 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 29 to 23 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $6.84MFull value: $6,835,508 · USD · 30 Jun 2026
    to
    $11.22MFull value: $11,217,562 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 23 institutions filings for Q3 2026.

Open SEC evidence

Security key

58468P206

13F reference period

Q3 2026

13F holders

23

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
MNOV
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
3D Investment Partners Pte. Ltd. 9.9% $7,633,414 4,862,047 3D Investment Partners Pte. Ltd. 25 Sep 2026
VANGUARD CAPITAL MANAGEMENT LLC 7.2% $5,944,124 3,548,731 Vanguard Capital Management 30 Sep 2026
As of 30 Sep 2026, 23 institutional investors reported holding
6.69MFull value: 6,693,601 · shares · 30 Sep 2026
shares of MEDICINOVA INC - Common Stock (MNOV). This represents 14% of the company’s total
49.29MFull value: 49,287,931 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 20 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
13%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 6.6% 3,236,928 0% $5,421,854
Essex Woodlands Management, Inc. 2.2% 1,105,941 0.57% $1,857,981
GOLDMAN SACHS GROUP INC 1.2% 615,863 0% $1,031,571
GEODE CAPITAL MANAGEMENT, LLC 1.1% 522,222 0% $874,973
VANGUARD FIDUCIARY TRUST CO 0.6% 296,204 0% $496,142
RENAISSANCE TECHNOLOGIES LLC 0.46% 224,595 0% $376,197
STATE STREET CORP 0.39% 193,698 0% $324,444
TWO SIGMA INVESTMENTS, LP 0.25% 124,160 0% $207,968
SBI Securities Co., Ltd. 0.11% 53,389 0% $89,427
DIMENSIONAL FUND ADVISORS LP 0.1% 50,552 0% $84,675
Empowered Funds, LLC 0.1% 49,430 0% $82,795
Schonfeld Strategic Advisors LLC 0.06% 27,961 0% $46,834
Qube Research & Technologies Ltd 0.05% 23,648 0% $39,610
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.04% 19,295 0% $32,319
XTX Topco Ltd 0.04% 18,643 0% $31,227
Aster Capital Management (DIFC) Ltd 0.04% 18,322 0.01% $30,689
Jump Financial, LLC 0.04% 17,730 0% $29,698
Vanguard Global Advisers, LLC 0.03% 15,599 0% $26,128
HighTower Advisors, LLC 0.02% 10,000 0% $16,750
GROUP ONE TRADING LLC 0% 1,893 0% $3,171

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 6,693,601 $11,217,562 +$5,837,575 $1.68 23
2026 Q2 5,177,954 $6,835,508 -$301,924 $1.32 29
2026 Q1 5,404,340 $7,404,208 -$63,009 $1.37 30
2025 Q4 5,253,134 $6,882,144 +$163,841 $1.31 32
2025 Q3 5,128,066 $6,488,274 -$53,429 $1.27 25
2025 Q2 5,170,823 $6,774,834 -$46,809 $1.31 23
2025 Q1 5,202,397 $7,595,262 -$90,880 $1.46 27
2024 Q4 5,231,027 $10,985,693 +$513,458 $2.10 29
2024 Q3 4,929,543 $10,359,167 +$566,392 $2.10 30
2024 Q2 4,654,818 $6,706,694 -$28,677 $1.44 30
2024 Q1 4,674,226 $6,779,462 -$233,962 $1.45 32
2023 Q4 4,834,478 $7,252,924 -$349,778 $1.50 33
2023 Q3 5,006,666 $10,465,142 -$860,474 $2.09 30
2023 Q2 5,381,224 $12,394,508 -$434,062 $2.30 33
2023 Q1 5,588,064 $12,068,850 -$1,337,380 $2.16 40
2022 Q4 6,208,931 $12,727,368 -$1,307,417 $2.05 40
2022 Q3 6,844,003 $14,850,894 -$257,655 $2.17 32
2022 Q2 6,960,285 $17,609,042 -$424,414 $2.53 33
2022 Q1 7,128,380 $19,033,559 -$1,334,125 $2.67 29
2021 Q4 7,622,755 $20,425,618 -$239,811 $2.68 40
2021 Q3 7,648,159 $28,991,165 -$3,061,081 $3.79 38
2021 Q2 8,411,276 $35,749,549 -$15,268,151 $4.25 52
2021 Q1 11,786,829 $59,521,826 +$2,083,384 $5.05 57
2020 Q4 11,344,150 $59,675,777 +$6,680,486 $5.26 54
2020 Q3 10,076,079 $52,789,386 +$2,838,430 $5.24 51
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .